• Rentokil Initial published a transcript of its H1 2026 interim results call attended by Group CEO Mike Duffy, Group CFO Paul Edgecliffe-Johnson.
• Revenue rose 4.5% to USD 3.59 billion on 3.6% organic growth; operating profit increased 6.6% to USD 556 million; margin improved 30 bps to 15.5%.
• Free cash flow grew 12.8% with 96% conversion; leverage fell to 2.4x; interim dividend lifted 8%.
• North America revenue increased 4.2% to USD 2.2 billion; organic growth 3.7%; operating profit rose 10.2% to USD 393 million; margin improved to 17.9%.
• Management flagged weaker North America residential lead flow late in Q2 into July, driven mainly by softer termite leads in housing-pressured geographies.
• US commercial was cited as lagging on conversion and retention, partly tied to rationalisation of legacy Terminix commercial contracts; Residential and Commercial will be separated for accountability.
• North America cost program delivered USD 45 million gross savings in H1, USD 28 million net; exited H1 at about USD 90 million annualised gross run-rate.
• North America 2027 20% margin target was withdrawn, citing planned reinvestment into growth, mix from lower-margin Business Services, redeployment of resources.
• Legacy termite provision increased by USD 44 million; full-year provision cash outflow guidance raised to USD 115 million to USD 125 million.
• Bolt-on M&A spend outlook cut to USD 120 million; H1 spend was USD 39 million across 14 acquisitions; full-year profit outlook kept in line with market expectations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rentokil Initial plc published the original content used to generate this news brief on August 03, 2026, and is solely responsible for the information contained therein.